RETRACTED ARTICLE: Safety and effectiveness of high-dose methotrexate (over 8 mg/week) in 2838 Japanese patients with rheumatoid arthritis: A postmarketing surveillance report.

Suzuki Y, Sugiyama N, Fukuma Y, Sugiyama N, Kokubo T

Open source

DOI
10.1080/14397595.2017.1304857
Published
2020 Jan
Container
Modern rheumatology
Publisher
Not recorded
Open access
no

Credibility signals

serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/14397595.2017.1304857,
  title = {RETRACTED ARTICLE: Safety and effectiveness of high-dose methotrexate (over 8 mg/week) in 2838 Japanese patients with rheumatoid arthritis: A postmarketing surveillance report.},
  author = {Suzuki Y and Sugiyama N and Fukuma Y and Sugiyama N and Kokubo T},
  year = {2020},
  journal = {Modern rheumatology},
  doi = {10.1080/14397595.2017.1304857},
  url = {https://doi.org/10.1080/14397595.2017.1304857}
}

RIS

TY  - JOUR
TI  - RETRACTED ARTICLE: Safety and effectiveness of high-dose methotrexate (over 8 mg/week) in 2838 Japanese patients with rheumatoid arthritis: A postmarketing surveillance report.
AU  - Suzuki Y
AU  - Sugiyama N
AU  - Fukuma Y
AU  - Sugiyama N
AU  - Kokubo T
PY  - 2020
JO  - Modern rheumatology
DO  - 10.1080/14397595.2017.1304857
UR  - https://doi.org/10.1080/14397595.2017.1304857
ER  - 

APA

Y, S., N, S., Y, F., N, S., & T, K. (2020). RETRACTED ARTICLE: Safety and effectiveness of high-dose methotrexate (over 8 mg/week) in 2838 Japanese patients with rheumatoid arthritis: A postmarketing surveillance report.. Modern rheumatology. https://doi.org/10.1080/14397595.2017.1304857

Source records